Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

Europe - FRA:NVJP - BE0974320526 - Common Stock

12.59 EUR
-0.56 (-4.26%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

4

Overall NVJP gets a fundamental rating of 4 out of 10. We evaluated NVJP against 66 industry peers in the Chemicals industry. There are concerns on the financial health of NVJP while its profitability can be described as average. NVJP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
NVJP had a positive operating cash flow in the past year.
NVJP had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NVJP had a positive operating cash flow.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

NVJP's Return On Assets of 1.50% is in line compared to the rest of the industry. NVJP outperforms 51.52% of its industry peers.
Looking at the Return On Equity, with a value of 6.30%, NVJP is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
NVJP has a better Return On Invested Capital (6.40%) than 69.70% of its industry peers.
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROIC 6.4%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

NVJP has a Profit Margin (0.80%) which is in line with its industry peers.
NVJP's Operating Margin of 2.57% is in line compared to the rest of the industry. NVJP outperforms 42.42% of its industry peers.
NVJP has a worse Gross Margin (7.76%) than 84.85% of its industry peers.
In the last couple of years the Gross Margin of NVJP has grown nicely.
Industry RankSector Rank
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NVJP is still creating some value.
The number of shares outstanding for NVJP remains at a similar level compared to 1 year ago.
The number of shares outstanding for NVJP remains at a similar level compared to 5 years ago.
NVJP has a worse debt/assets ratio than last year.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 2.71 indicates that NVJP is not a great score, but indicates only limited risk for bankruptcy at the moment.
NVJP has a Altman-Z score of 2.71. This is in the better half of the industry: NVJP outperforms 69.70% of its industry peers.
NVJP has a debt to FCF ratio of 50.79. This is a negative value and a sign of low solvency as NVJP would need 50.79 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 50.79, NVJP is in line with its industry, outperforming 42.42% of the companies in the same industry.
NVJP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
NVJP has a Debt to Equity ratio of 1.10. This is amonst the worse of the industry: NVJP underperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Altman-Z 2.71
ROIC/WACC1.05
WACC6.11%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.37. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
NVJP's Current ratio of 1.37 is on the low side compared to the rest of the industry. NVJP is outperformed by 71.21% of its industry peers.
NVJP has a Quick Ratio of 1.37. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
NVJP has a Quick ratio of 0.72. This is amonst the worse of the industry: NVJP underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.72
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for NVJP have decreased strongly by -18.12% in the last year.
The Earnings Per Share has been decreasing by -3.85% on average over the past years.
The Revenue has been growing slightly by 2.55% in the past year.
NVJP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.21% yearly.
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%

3.2 Future

NVJP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.13% yearly.
Based on estimates for the next years, NVJP will show a small growth in Revenue. The Revenue will grow by 1.45% on average per year.
EPS Next Y19.7%
EPS Next 2Y12.28%
EPS Next 3Y10.35%
EPS Next 5Y7.13%
Revenue Next Year-2.5%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.14, the valuation of NVJP can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of NVJP indicates a rather cheap valuation: NVJP is cheaper than 90.91% of the companies listed in the same industry.
NVJP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
NVJP is valuated reasonably with a Price/Forward Earnings ratio of 9.42.
NVJP's Price/Forward Earnings ratio is rather cheap when compared to the industry. NVJP is cheaper than 90.91% of the companies in the same industry.
NVJP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 11.14
Fwd PE 9.42
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.18% of the companies in the same industry are more expensive than NVJP, based on the Enterprise Value to EBITDA ratio.
NVJP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 54.99
EV/EBITDA 7.15
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

NVJP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y12.28%
EPS Next 3Y10.35%

4

5. Dividend

5.1 Amount

NVJP has a Yearly Dividend Yield of 2.65%.
NVJP's Dividend Yield is a higher than the industry average which is at 3.04.
Compared to an average S&P500 Dividend Yield of 2.38, NVJP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.65%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NVJP pays out 93.29% of its income as dividend. This is not a sustainable payout ratio.
NVJP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP93.29%
EPS Next 2Y12.28%
EPS Next 3Y10.35%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
NVJP.DE Dividend Payout.NVJP.DE Dividend Payout, showing the Payout Ratio.NVJP.DE Dividend Payout.PayoutRetained Earnings

UMICORE

FRA:NVJP (9/16/2025, 7:00:00 PM)

12.59

-0.56 (-4.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners38.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.10B
Analysts66.67
Price Target14.24 (13.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.65%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP93.29%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.65%
PT rev (3m)26.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)24.09%
EPS NY rev (3m)24.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)2.98%
Valuation
Industry RankSector Rank
PE 11.14
Fwd PE 9.42
P/S 0.19
P/FCF 54.99
P/OCF 6.6
P/B 1.52
P/tB 1.87
EV/EBITDA 7.15
EPS(TTM)1.13
EY8.98%
EPS(NY)1.34
Fwd EY10.62%
FCF(TTM)0.23
FCFY1.82%
OCF(TTM)1.91
OCFY15.15%
SpS65.35
BVpS8.29
TBVpS6.75
PEG (NY)0.57
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 6.3%
ROCE 8.18%
ROIC 6.4%
ROICexc 8.19%
ROICexgc 9.07%
OM 2.57%
PM (TTM) 0.8%
GM 7.76%
FCFM 0.35%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score5
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 50.79
Debt/EBITDA 3.22
Cap/Depr 144.97%
Cap/Sales 2.57%
Interest Coverage 4.12
Cash Conversion 67.19%
Profit Quality 43.79%
Current Ratio 1.37
Quick Ratio 0.72
Altman-Z 2.71
F-Score5
WACC6.11%
ROIC/WACC1.05
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.12%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%14.29%
EPS Next Y19.7%
EPS Next 2Y12.28%
EPS Next 3Y10.35%
EPS Next 5Y7.13%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-0.72%
Revenue Next Year-2.5%
Revenue Next 2Y2.11%
Revenue Next 3Y1.65%
Revenue Next 5Y1.45%
EBIT growth 1Y136.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.35%
EBIT Next 3Y19.67%
EBIT Next 5Y16.26%
FCF growth 1Y136.84%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-3.36%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%